Agilent Technologies (NYSE:A) CEO Sells $1,873,500.00 in Stock

Agilent Technologies, Inc. (NYSE:A) CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at $5,017,200. The trade was a 27.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Agilent Technologies Price Performance

Shares of A stock traded up $0.01 during midday trading on Friday, reaching $146.90. 1,289,513 shares of the company were exchanged, compared to its average volume of 1,893,069. The company’s 50 day moving average price is $137.27 and its two-hundred day moving average price is $123.50. The company has a market cap of $41.65 billion, a P/E ratio of 34.48, a PEG ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the firm posted $1.32 earnings per share. The business’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s payout ratio is currently 23.24%.

Hedge Funds Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. Brighton Jones LLC boosted its holdings in shares of Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares during the period. Wealthfront Advisers LLC boosted its stake in shares of Agilent Technologies by 1.4% during the 1st quarter. Wealthfront Advisers LLC now owns 17,364 shares of the medical research company’s stock valued at $2,031,000 after buying an additional 233 shares during the period. Larson Financial Group LLC increased its stake in shares of Agilent Technologies by 35.0% in the first quarter. Larson Financial Group LLC now owns 5,991 shares of the medical research company’s stock worth $701,000 after acquiring an additional 1,554 shares during the last quarter. Bailard Inc. boosted its position in Agilent Technologies by 6.6% during the first quarter. Bailard Inc. now owns 2,631 shares of the medical research company’s stock valued at $308,000 after purchasing an additional 163 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. purchased a new position in Agilent Technologies in the first quarter valued at about $324,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A has been the subject of several research reports. Robert W. Baird raised their target price on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. JPMorgan Chase & Co. upped their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Barclays lifted their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Evercore ISI increased their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. Finally, Wells Fargo & Company lifted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.